ArticleGenetics in medicine open2024

Casgevy (exagamglogene autotemcel) and Lyfgenia (lovotibeglogene autotemcel) for individuals 12 years and older with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOC): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).

Harry Lesmana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.